|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|---|---|
| Operating activities | ||||
| Net loss | ||||
| Adjustments to reconcile net loss to net cash used for operating activities: | ||||
| Income from Trust | ||||
| Stock-based compensation | ||||
| Changes in operating assets and liabilities: | ||||
| Prepaid Expenses | ||||
| Accounts payable and accrued expenses | ||||
| Accrued interest expense -related party | ||||
| Accrued interest expense - others | ||||
| Other assets | ||||
| Accounts payable | ||||
| Accrued expenses | ||||
| Net cash used in operating activities | ||||
| Investment held in Trust Account | ||||
| Cash withdrawn from Trust Account in connection with redemption | ||||
| Net cash provided by investing activities | ||||
| Financing activities | ||||
| Proceeds from Business Combination | ||||
| Redemption of ordinary shares | ||||
| Net cash provided by financing activities | ||||
| Net change in cash and cash equivalents | ||||
| Cash and cash equivalents at beginning of period | ||||
| Cash and cash equivalents at end of period | ||||
| Supplemental disclosure of non-cash investing and financing activities: | ||||
| Increase in investment held in Trust Account through issuance of promissory note | ||||
| Subsequent measurement of Common stock subject to possible redemption | ||||
| Remeasurement adjustment on class A ordinary shares subject to possible redemption | ||||
| Purchase of equipment through related party loan | ||||
| Deferred offering costs paid through related party loan | ||||
| Payment of promissory notes through related party loan | ||||
| Related Party | ||||
| Net liabilities assumed in Business Combination | ||||
| Related party loan settled in preferred stock pursuant to Debt Exchange Agreement | ||||
| Related party loan settled in common stock | ||||
| Promissory notes settled in common stock | ||||
Loading...